NASDAQ: ESLA
Estrella Immunopharma Inc Stock Ownership - Who owns Estrella Immunopharma?

Insider buying vs selling

Have Estrella Immunopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ESLA insiders and whales buy or sell their stock.

ESLA Shareholders

What type of owners hold Estrella Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eureka Therapeutics Inc69.89%25,277,831$27.68MInsider
Jianwei Li6.63%2,399,490$2.63MInsider
Tradeup Acquisition Sponsor LLC3.17%1,145,760$1.25MInsider
Cheng Liu0.82%297,437$325.69kInsider
Jiandong Xu0.73%264,388$289.50kInsider
Hong Zhang0.66%240,481$263.33kInsider
Geode Capital Management LLC0.26%93,418$102.29kInstitution
Ubs Group Ag0.18%65,167$71.36kInstitution
Atw Spac Management LLC0.11%40,000$43.80kInstitution
Blackrock Inc0.07%25,118$27.50kInstitution

1 of 3

ESLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESLA0.81%82.00%
BOLD58.13%23.91%
ITRM3.60%65.90%
XLO42.08%57.92%Net Buying
BLUE18.67%81.33%Net SellingNet Selling

Estrella Immunopharma Stock Ownership FAQ

Who owns Estrella Immunopharma?

Estrella Immunopharma (NASDAQ: ESLA) is owned by 0.81% institutional shareholders, 82.00% Estrella Immunopharma insiders, and 17.19% retail investors. Eureka Therapeutics Inc is the largest individual Estrella Immunopharma shareholder, owning 25.28M shares representing 69.89% of the company. Eureka Therapeutics Inc's Estrella Immunopharma shares are currently valued at $27.30M.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.